Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer.
Plumber SA, Tate T, Al-Ahmadie H, Chen X, Choi W, Basar M, Lu C, Viny A, Batourina E, Li J, Gretarsson K, Alija B, Molotkov A, Wiessner G, Lee BHL, McKiernan J, McConkey DJ, Dinney C, Czerniak B, Mendelsohn CL.
Plumber SA, et al.
Nat Commun. 2024 Aug 2;15(1):6538. doi: 10.1038/s41467-024-50678-2.
Nat Commun. 2024.
PMID: 39095358
Free PMC article.